The FK506-binding protein 51 (FKBP51) has emerged as a key regulator of endocrine stress responses in mammals and as a potential therapeutic target for stress-related disorders (depression, post-traumatic stress disorder), metabolic disorders (obesity and diabetes) and chronic pain. Recently, FKBP51 has been implicated in several cellular pathways and numerous interacting protein partners have been reported. However, no consensus on the underlying molecular mechanisms has yet emerged. Here, we review the protein interaction partners reported for FKBP51, the proposed pathways involved, their relevance to FKBP51’s physiological function(s), the interplay with other FKBPs, and implications for the development of FKBP51-directed drugs
Psychotropic medications target glycogen synthase kinase 3β (GSK3β), but the functional integration ...
The co-chaperone FKBP5 is a stress-responsive protein-regulating stress reactivity, and its genetic ...
The FK506-binding protein 51 (FKBP51, encoded by the FKBP5 gene) is an established risk factor for s...
The FK506 Binding Protein 51 (FKBP51) is an identified risk factor for a variety of psychiatric diso...
FK506 binding protein 51 (FKBP51) is an Hsp90 co-chaperone and regulator of the glucocorticoid recep...
Background: Obesity, Type 2 diabetes (T2D) as well as stress-related disorders are rising public hea...
The FK506 binding protein 51 (FKBP51) plays a role in psychiatric diseases such as major depression ...
This review portraits FK506 binding protein (FKBP) 51 as reactivity protein and collates recent publ...
FKBP51 and FKBP52 are diverse regulators of steroid hormone receptor signaling, including receptor m...
The FK506-binding protein 51 (FICBP51) is a promising drug target for the treatment of stress-relate...
The FK506-binding protein 51 (FKBP51) is an Hsp90-associated co-chaperone which regulates steroid re...
The FK506-binding protein 51 (FKBP51) is a promising drug target for the treatment of stress-related...
<div><p>The FK506-binding protein 51 (FKBP51) is an Hsp90-associated co-chaperone which regulates st...
Among the chaperones and co-chaperones regulating the glucocorticoid receptor (GR), FK506 binding pr...
Psychotropic medications target glycogen synthase kinase 3β (GSK3β), but the functional integration ...
The co-chaperone FKBP5 is a stress-responsive protein-regulating stress reactivity, and its genetic ...
The FK506-binding protein 51 (FKBP51, encoded by the FKBP5 gene) is an established risk factor for s...
The FK506 Binding Protein 51 (FKBP51) is an identified risk factor for a variety of psychiatric diso...
FK506 binding protein 51 (FKBP51) is an Hsp90 co-chaperone and regulator of the glucocorticoid recep...
Background: Obesity, Type 2 diabetes (T2D) as well as stress-related disorders are rising public hea...
The FK506 binding protein 51 (FKBP51) plays a role in psychiatric diseases such as major depression ...
This review portraits FK506 binding protein (FKBP) 51 as reactivity protein and collates recent publ...
FKBP51 and FKBP52 are diverse regulators of steroid hormone receptor signaling, including receptor m...
The FK506-binding protein 51 (FICBP51) is a promising drug target for the treatment of stress-relate...
The FK506-binding protein 51 (FKBP51) is an Hsp90-associated co-chaperone which regulates steroid re...
The FK506-binding protein 51 (FKBP51) is a promising drug target for the treatment of stress-related...
<div><p>The FK506-binding protein 51 (FKBP51) is an Hsp90-associated co-chaperone which regulates st...
Among the chaperones and co-chaperones regulating the glucocorticoid receptor (GR), FK506 binding pr...
Psychotropic medications target glycogen synthase kinase 3β (GSK3β), but the functional integration ...
The co-chaperone FKBP5 is a stress-responsive protein-regulating stress reactivity, and its genetic ...
The FK506-binding protein 51 (FKBP51, encoded by the FKBP5 gene) is an established risk factor for s...